Saturday, March 18, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Antimicrobial Resistance

New Type of Nanoparticle Biosensor for Threat Detection

by Global Biodefense Staff
June 4, 2012

A long-standing challenge of biosensors is how to efficiently and economically detect traces of chemicals or pathogens in large volumes of sample.  Researchers at the University of New South Wales (UNSW) in Sydney, Australia have developed a new class of biosensor that changes the detection paradigm to help overcome such obstacles.

The detector utilizes a technique which is most easily described as a sort of ‘reverse immunoassay.’ The detector distributes gold-coated magnetic nanoparticles labeled with selective antibodies into the sample. If the target analyte is present, some of the antibodies detach from the nanoparticles.

Then using a magnet, the nanoparticles are then assembled into a film between two electrodes and the electrical resistance is measured. The more analyte is present, the more antibodies leave the nanoparticles and the lower the resistance in the nanoparticle film.

“This new type of biosensor is rapid in response because the magnetic nanoparticle biosensors go and get the analyte rather than the usual approach of waiting for the analyte to find the sensing surface,” said Professor Justin Gooding.

The device, called a biochemresistor, can detect exceptionally small traces of contaminants in liquids in just 40 minutes. “The entire idea of the work was to develop a method that could allow us to detect rare species in large volumes in a reasonable amount of time,” said Gooding.  “This new idea has potential for defense, food safety and water quality applications.”

The team recently published a paper in the prestigious chemistry journal Angewandte Chemie describing how they successfully tested the new sensor by detecting small traces of the veterinary antibiotic enrofloxacin in milk samples.

“Our biochemresistor was able to detect enrofloxacin in neat milk in 40 minutes, at levels as low as one nanogram in a litre of milk. To put that number in perspective, a nanogram is a billionth of a gram and is the mass of a single cell.”

The research team included partners from the Australian Centre for NanoMedicine and the former ARC Centre of Excellence for Functional Nanomaterials at UNSW.

Tags: Chemical DetectionNanotech

Related Posts

New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
New Virus Discovered in Swiss Ticks
Biosurveillance

New Virus Discovered in Swiss Ticks

December 7, 2022
Why Do Some of the Outbreak Genomes Have More Mutations Than Others?
Biosurveillance

Virginia Institutes Partner to Join National Pathogen Genomics Centers of Excellence Network

October 25, 2022
Researcher holds a pipette
Biodetection

These Nanotech Bubbles Burst When They Detect Viruses in the Air

October 25, 2022
Load More

Latest News

Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023
Biodefense Headlines – 24 January 2023

Biodefense Headlines – 24 January 2023

January 24, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are okay with it.OkPrivacy policy